Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,191.00
-18.00 (-1.49%)
At close: Mar 9, 2026
Hikma Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 402 | 359 | 190 | 188 | 421 | Upgrade
|
| Depreciation & Amortization | 204 | 189 | 190 | 185 | 169 | Upgrade
|
| Other Amortization | 8 | 8 | 8 | 8 | 11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1 | 1 | - | -6 | 1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 26 | -29 | 61 | 179 | -35 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1 | -1 | -2 | 2 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | -1 | - | - | 1 | Upgrade
|
| Stock-Based Compensation | 23 | 27 | 25 | 22 | 29 | Upgrade
|
| Other Operating Activities | 24 | 146 | 56 | 83 | 69 | Upgrade
|
| Change in Accounts Receivable | -97 | -144 | -24 | 4 | -166 | Upgrade
|
| Change in Inventory | -86 | -112 | -115 | -102 | 38 | Upgrade
|
| Change in Accounts Payable | 38 | 78 | 88 | 16 | 14 | Upgrade
|
| Change in Other Net Operating Assets | -106 | 43 | 131 | -49 | 86 | Upgrade
|
| Operating Cash Flow | 436 | 564 | 608 | 530 | 638 | Upgrade
|
| Operating Cash Flow Growth | -22.70% | -7.24% | 14.72% | -16.93% | 37.50% | Upgrade
|
| Capital Expenditures | -197 | -165 | -169 | -138 | -145 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 10 | 18 | 1 | - | Upgrade
|
| Cash Acquisitions | - | -150 | -98 | -373 | - | Upgrade
|
| Divestitures | - | - | - | -1 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -120 | -70 | -35 | -78 | -84 | Upgrade
|
| Investment in Securities | -3 | -2 | -26 | -15 | 3 | Upgrade
|
| Other Investing Activities | -68 | -4 | -23 | -3 | -12 | Upgrade
|
| Investing Cash Flow | -388 | -381 | -333 | -607 | -238 | Upgrade
|
| Short-Term Debt Issued | 349 | 387 | 437 | 380 | 383 | Upgrade
|
| Long-Term Debt Issued | 2,402 | 684 | 778 | 1,401 | 10 | Upgrade
|
| Total Debt Issued | 2,751 | 1,071 | 1,215 | 1,781 | 393 | Upgrade
|
| Short-Term Debt Repaid | -357 | -411 | -467 | -363 | -431 | Upgrade
|
| Long-Term Debt Repaid | -2,104 | -557 | -851 | -971 | -76 | Upgrade
|
| Total Debt Repaid | -2,461 | -968 | -1,318 | -1,334 | -507 | Upgrade
|
| Net Debt Issued (Repaid) | 290 | 103 | -103 | 447 | -114 | Upgrade
|
| Repurchase of Common Stock | -36 | -38 | - | -300 | - | Upgrade
|
| Common Dividends Paid | -185 | -175 | -137 | -125 | -120 | Upgrade
|
| Other Financing Activities | -94 | -78 | -97 | -80 | -53 | Upgrade
|
| Financing Cash Flow | -25 | -188 | -337 | -58 | -287 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6 | -12 | -3 | -21 | -10 | Upgrade
|
| Net Cash Flow | 29 | -17 | -65 | -156 | 103 | Upgrade
|
| Free Cash Flow | 239 | 399 | 439 | 392 | 493 | Upgrade
|
| Free Cash Flow Growth | -40.10% | -9.11% | 11.99% | -20.49% | 68.84% | Upgrade
|
| Free Cash Flow Margin | 7.14% | 12.76% | 15.27% | 15.57% | 19.31% | Upgrade
|
| Free Cash Flow Per Share | 1.07 | 1.78 | 1.97 | 1.74 | 2.12 | Upgrade
|
| Cash Interest Paid | 83 | 84 | 82 | 68 | 50 | Upgrade
|
| Cash Income Tax Paid | 124 | 125 | 129 | 55 | 129 | Upgrade
|
| Levered Free Cash Flow | -119.63 | 290.13 | 449 | 244.38 | 269.75 | Upgrade
|
| Unlevered Free Cash Flow | -53.38 | 337 | 494.63 | 281.25 | 296.63 | Upgrade
|
| Change in Working Capital | -251 | -135 | 80 | -131 | -28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.